COVID-19 Blood Plasma Clinical Trials

JHCEIRS Investigators Receive Federal Funding for Nationwide Study

Drs. Andrew Pekosz and Sabra Klein are part of a collaboration at Johns Hopkins University that will evaluate the effectiveness of convalescent blood plasma therapy against SARS-CoV-2 infection.

CEIRS Generated Reagents

Connecting Researchers to Influenza Reagents

The CEIRS Reagents webpage is a searchable and filterable catalog of over 5,000 unique, influenza-specific reagents developed by CEIRS researchers. These reagents (plasmids, proteins, antibodies, and viruses) are available to the broader scientific community and can be requested through the CEIRS Reagents webpage.

View Page

The CEIRS Network

A Program of the National Institute of Allergy and Infectious Diseases

Due to the ever present threat of an influenza pandemic, the NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS) program was established to support the research agenda of the HHS Pandemic Influenza Plan.

The CEIRS Centers

Comprehensive Flu Science - Worldwide

Learn More

Capturing the Flu in Colombia with Dr. Dib

Juan C. Dib, MD, MPH/TM, PhD, discusses his career as a multidisciplinary scientist and physician working with indigenous peoples to study influenza and other tropical infectious diseases.

Improving Influenza Vaccines

CEIRS Trainee Spotlight featuring Teddy John Wohlbold

Mr. Teddy John Wohlbold shares his experience with the CEIRS Training Program and his work on refining antibody responses to the flu.

B-cells, Boosters, and Precision Vaccines

David Topham, PhD, co-Principal Investigator of the New York Influenza Center of Excellence (NYICE), discusses the relationship between an individual’s immune response and seasonal flu viruses and a translational approach to influenza research.

Centers of Excellence for Influenza Research and Surveillance (CEIRS)

The National Institute of Allergy and Infectious Diseases (NIAID) Centers of Excellence for Influenza Research and Surveillance (CEIRS) program is a multidisciplinary and collaborative network of research centers. Investigators perform surveillance integrated with research on host immune response, viral pathogenesis, and the factors that control the emergence and transmission of influenza viruses. The overall goal of the CEIRS Network is to provide the information and public health tools needed to control the impact of epidemic influenza and the threat of pandemic influenza.

This project is funded by the National Institute of Allergy and Infectious Diseases, National Institutes of Health

Centers of Excellence for Influenza Research and Surveillance

CEIRS Responds to COVID-19